| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2973025 | The Journal of Heart and Lung Transplantation | 2006 | 9 Pages |
Abstract
Changing from CsA to a combined therapy of MMF with S1P agonist is a promising strategy in clinical transplantation to overcome CI-induced nephrotoxicity and chronic rejection.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Jun MD, Chihiro MD, Shinji MSc, Tokutaro MSc, Yoji PhD, Masafumi MD, PhD, Takashi MD, PhD, Kohei MD, PhD, Eiji MD, PhD,